Public-Private Partnerships for the Development of New Devices for Screening and Treatment of Cervical Precancer for Emerging Economies

Abstract 74PATH is a nonprofit organization involved in the development of new technologies for screening and treatment of precancerous lesions of the uterine cervix for the last 25 years. PATH had private-public partnerships with four private companies for the design, development, improvement, and/or field validation of two new technologies for screening (careHPV and OncoE6 Cervical Test) and two devices for treatment (CryoPen and the Liger Thermal Coagulator). This experience allows us to identify some commonalities among those companies: they all had the technical or scientific background for developing or improving the technologies needed, they were committed to creating technologies suitable for emerging economies, and their knowledge or presence in low-resource countries was limited.The characteristics of our collaboration with the private companies varied depending on the initial status of the technology. Two of the companies already had marketed technologies that required adaptation for suitabilit...